|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Rhode Island Hospital
2 Brown University
* To whom correspondence should be addressed. E-mail: jose_behar{at}brown.edu.
BACKGROUND: Progesterone (P4) inhibits the gastrointestinal muscle contraction by downregulating G
q/11 proteins that mediate contraction, by upregulating G
s proteins that mediate relaxation and by altering the pattern of COX enzymes and prostaglandins. AIM: To examine whether P4 treatment of guinea pigs in vivo affects basal colon motility (BMI) by altering the levels and actions of PGF2
and PGE2. METHODS: Guinea pigs were treated with IM progesterone for 4 days. The BMI, the PGF2
induced contraction and PGE2 induced relaxation were examined in muscle strips and cells. The levels of PGF2
and PGE2 were measured by radioimmunoassay. RESULTS: Treatment with P4 reduced the BMI, the levels of PGF2
and PGF2
induced contraction. P4 increased PGE2 levels and PGE2 induced relaxation. Pretreatment with IM RU-486 (10 mg/kg/day), a P4 receptor antagonist, 1 h prior to P4 blocked the actions of P4. The PGF2
antagonist Al-1180 abolished BMI and PGF2
induced contraction. NEM, that block unoccupied membrane receptors, blocked Ach and VIP actions but had no effect on PGF2
and PGE2 effects. A COX-1 inhibitor decreased and a COX-2 inhibitor increased PGF2
levels, GTP
S increased and GDP
S decreased the levels of PGF2
. G
q/11 protein antibodies (Abs) reduced PGF2
levels and G
i3 Abs blocked its motor actions. G
s Abs increased PGF2
but decreased PGE2 levels. CONCLUSION: P4 decreases BMI by reducing PGF2
levels caused by downregulation of G
q/11 and PGF2
induced contraction was blocked by down regulating G
i3. P4 also decreased the BMI by increasing PGE2 levels and PGE2 induced relaxation by upregulating G
s proteins.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |